Next report date
Report period
Q2 2024
EPS estimate
—
Revenue estimate
—
−328.96 MCNY
111.08 MCNY
289.85 M
Om FRONTIER BIOTECHNOLOGIES INC.
Sektor
Bransch
VD
Chang Jin Wang
Webbplats
Huvudkvarter
Nanjing
Employees (FY)
395
Grundat
2013
ISIN
CNE100005XF5
FIGI
BBG00PZ7WBM6
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
